Patrick M. Navolanic

4.4k total citations · 3 hit papers
23 papers, 3.5k citations indexed

About

Patrick M. Navolanic is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Patrick M. Navolanic has authored 23 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Patrick M. Navolanic's work include Synthesis and biological activity (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Melanoma and MAPK Pathways (5 papers). Patrick M. Navolanic is often cited by papers focused on Synthesis and biological activity (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Melanoma and MAPK Pathways (5 papers). Patrick M. Navolanic collaborates with scholars based in United States, Italy and Ukraine. Patrick M. Navolanic's co-authors include James A. McCubrey, Linda S. Steelman, Richard A. Franklin, William L. Blalock, J G Shelton, Fuju Chang, Massimo Libra, John Tayu Lee, Fumin Chang and Franca Stivala and has published in prestigious journals such as Oncogene, Biology of Reproduction and Journal of Clinical Pathology.

In The Last Decade

Patrick M. Navolanic

23 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

2003 999 citations Fuju Chang, Patrick M. Navolanic et al. Leukemia profile →
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention

2003 577 citations Fuju Chang, Linda S. Steelman et al. Leukemia profile →
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

2006 550 citations James A. McCubrey, Linda S. Steelman et al. Advances in Enzyme Regulation profile →

Peers

Countries citing papers authored by Patrick M. Navolanic

Since Specialization

Citations

This map shows the geographic impact of Patrick M. Navolanic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Navolanic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Navolanic more than expected).

Fields of papers citing papers by Patrick M. Navolanic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. Navolanic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Navolanic. The network helps show where Patrick M. Navolanic may publish in the future.

Co-authorship network of co-authors of Patrick M. Navolanic

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. Navolanic. A scholar is included among the top collaborators of Patrick M. Navolanic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. Navolanic. Patrick M. Navolanic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells 2011 ·Cell Cycle ·Linda S. Steelman, Patrick M. Navolanic, William H. Chappell, Stephen L. Abrams, Ellis W.T. Wong, Alberto M. Martelli, Lucio Cocco, Franca Stivala, Massimo Libra, Ferdinando Nicoletti, Л. Б. Дробот, Richard A. Franklin, James A. McCubrey	70
2	Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors 2008 ·Oncogene ·Linda S. Steelman, Patrick M. Navolanic, Melissa L. Sokolosky, (unknown), Brian D. Lehmann, William H. Chappell, Steven L. Abrams, Ellis W.T. Wong, Kristin M. Stadelman, David M. Terrian, Nicholas R. Leslie, A M Martelli, Franca Stivala, Massimo Libra, Richard A. Franklin, James A. McCubrey	130
3	Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review) 2008 ·Molecular Medicine Reports ·James A. McCubrey, Antonio Bonati, Massimo Libra, Franca Stivala, Alberto M. Martelli, Richard A. Franklin, Patrick M. Navolanic, Linda S. Steelman	5
4	Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 2006 ·Journal of Clinical Pathology ·Massimo Libra, Salvatore Santo Signorelli, Ylenia Bevelacqua, Patrick M. Navolanic, Valentina Bevelacqua, Jerry Polesel, Renato Talamini, Franca Stivala, María Clorinda Mazzarino, Grazia Malaponte	67
5	Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance breakdown → 2006 ·Advances in Enzyme Regulation ·James A. McCubrey, Linda S. Steelman, Steven L. Abrams, John Tayu Lee, Fumin Chang, Fred E. Bertrand, Patrick M. Navolanic, David M. Terrian, Richard A. Franklin, (unknown), Jeffrey L. Salisbury, María Clorinda Mazzarino, Franca Stivala, Massimo Libra	550
6	A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin 2006 ·Modern Pathology ·Antonino Carbone, Annunziata Gloghini, Massimo Libra, Daniela Gasparotto, Patrick M. Navolanic, Michele Spina, Umberto Tirelli	21
7	Analysis of BRAF Mutation in Primary and Metastatic Melanoma 2005 ·Cell Cycle ·Massimo Libra, Grazia Malaponte, Patrick M. Navolanic, Pietro Gangemi, Valentina Bevelacqua, Lidia Proietti, (unknown), Franca Stivala, María Clorinda Mazzarino, Salvatore Travali, James A. McCubrey	83
8	Aggressive forms of non-Hodgkin's lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses 2005 ·International Journal of Oncology ·Massimo Libra, Annunziata Gloghini, Vallì De Re, Maurizio Rupolo, Patrick M. Navolanic, Daniela Gasparotto, F Stivala, Michele Spina, Mauro Boiocchi, Antonino Carbone	8
9	Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 2005 ·Vascular Medicine ·Salvatore Santo Signorelli, Grazia Malaponte, Massimo Libra, Luigi Di Pino, Gabriella Celotta, Valentina Bevelacqua, (unknown), (unknown), Manuela Indelicato, Patrick M. Navolanic, Giuseppe Pennisi, María Clorinda Mazzarino	104
10	Second Primary Lymphoma or Recurrence: A Dilemma Solved by VDJ Rearrangement Analysis 2004 ·Leukemia & lymphoma ·Massimo Libra, Vallì De Re, Annunziata Gloghini, Patrick M. Navolanic, Antonino Carbone, Mauro Boiocchi	13
11	Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy 2004 ·BMC Cancer ·Massimo Libra, Patrick M. Navolanic, Renato Talamini, Erika Cecchin, Franca Sartor, Salvatore Tumolo, (unknown), Salvatore Travali, Mauro Boiocchi, Giuseppe Toffoli	25
12	Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia 2003 ·Leukemia ·William L. Blalock, Patrick M. Navolanic, Linda S. Steelman, J G Shelton, (unknown), (unknown), Richard A. Franklin, Amer M. Mirza, Martin McMahon, M. K. White, James A. McCubrey	50
13	Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention breakdown → 2003 ·Leukemia ·Fuju Chang, Linda S. Steelman, (unknown), J G Shelton, Patrick M. Navolanic, William L. Blalock, Richard A. Franklin, James A. McCubrey	577
14	Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy breakdown → 2003 ·Leukemia ·Fuju Chang, (unknown), Patrick M. Navolanic, Linda S. Steelman, J G Shelton, William L. Blalock, Richard A. Franklin, James A. McCubrey	999
15	Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002 2003 ·Leukemia ·Patrick M. Navolanic, C-H Pui, Richard A. Larson, Michael R. Bishop, Tillman Pearce, Mitchell S. Cairo, SJ Goldman, (unknown), Carl Shanholtz, John P. Leonard, James A. McCubrey	69
16	Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance. 2003 ·PubMed ·Julianne M. Davis, Patrick M. Navolanic, Caroline Weinstein‐Oppenheimer, Linda S. Steelman, Wei Hu, Marina Konopleva, Mikhail V. Blagosklonny, James A. McCubrey	96
17	EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review) 2003 ·International Journal of Oncology ·Patrick M. Navolanic, Linda S. Steelman, James A. McCubrey	150
18	Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). 2003 ·PubMed ·Fumin Chang, Linda S. Steelman, John G. Shelton, John Tayu Lee, Patrick M. Navolanic, William L. Blalock, Richard A. Franklin, James A. McCubrey	332
19	Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. 2001 ·PubMed ·Caroline Weinstein‐Oppenheimer, Carlos Henríquez‐Roldán, Julianne M. Davis, Patrick M. Navolanic, (unknown), LS Steelman, Richard A. Franklin, (unknown), Martin McMahon, James A. McCubrey	72
20	Identification of Isoforms of a Mitotic Motor in Mammalian Spermatogenesis1 2000 ·Biology of Reproduction ·Patrick M. Navolanic, Ann O. Sperry	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact